课题基金 / 基金详情

Identification of Novel Inhibitors of the Acquired EGFR C797S Mutation in Non-Small Cell Lung Cancer

Identification of Novel Inhibitors of the Acquired EGFR C797S Mutation in Non-Small Cell Lung Cancer
非小细胞肺癌中获得性 EGFR C797S 突变的新型抑制剂的鉴定
批准号：
338933
负责人：
Saraon Punit
金额：
$9.83万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-11-01 至 2018-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=338933&lang=en
关键词：
Cell Signalling Epidermal Growth Factor Receptor (Egfr) High-Throughput Screening Mammalian Membrane Two-Hybrid (Mamth) Assay Non-Small Cell Lung Cancer Protein-Protein Interactions Therapeutic Target

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung cancer, and in particular the most common subtype non-small cell lung cancer (NSCLC), representing 80% of all lung tumors, is the leading cause of cancer-related mortality worldwide. Proteins are the basic building blocks of a cell, which carry out d
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金